• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Emergent Biosolutions Inc

+ Add to Watchlist

EBS:US

22.9700 USD 0.0600 0.26%

As of 20:04:03 ET on 07/11/2014.

Snapshot for Emergent Biosolutions Inc (EBS)

Open: 22.8400 Day's Range: 22.7400 - 22.9900 Volume: 135,385
Previous Close: 22.9100 52wk Range: 15.1100 - 28.4800 1-Yr Rtn: +34.72%

Stock Chart for EBS

No chart data available.
  • EBS:US 22.9700
  • 1D
  • 1M
  • 1Y
22.9100
Interactive EBS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for EBS

Current P/E Ratio (ttm) 32.6988
Estimated P/E(12/2014) 21.8762
Relative P/E vs. SPX 1.8161
Earnings Per Share (USD) (ttm) 0.7025
Est. EPS (USD) (12/2014) 1.0500
Est. PEG Ratio -
Market Cap (M USD) 859.34
Shares Outstanding (M) 37.41
30 Day Average Volume 240,284
Price/Book (mrq) 1.7946
Price/Sale (ttm) 2.5828
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for EBS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for EBS

Emergent Biosolutions, Inc. develops and produces immunobiotics, pharmaceutical products that assist the body's immune system to prevent or treat disease. The Company produces a vaccine for anthrax.

Fuad El-HibriChairmanDaniel J Abdun-NabiPresident/CEO
Adam HaveyExec VP/President:BiodefenseBarry A LabingerExec VP/Pres:Biosciences Div
More Company Profile & Key Executives for EBS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil